Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers

Gut

Volumn 45, Issue 2, 1999, Pages 252-258

  Adachi, Y ^a   Yamamoto, H ^a   Itoh, F ^a   Hinoda, Y ^a   Okada, Y ^b   Imai, K ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Human; Matrilysin; Matrix metalloproteinase; Metastasis; MMP 7; Transfection

Indexed keywords

CASEIN; COMPLEMENTARY DNA; MATRILYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SUBCUTANEOUS TISSUE TUMOR; TUMOR XENOGRAFT; ZYMOGRAPHY;

EID: 0032816631     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.2.252     Document Type: Article

References (36)

1. Brikedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
2. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumour invasion: from correlation and causality to the clinic. Semin Cancer Biol 1996;7:147-54.
3. Crawford HC, Matrisian LM. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 1996;49:20-37.
4. Baragi VM, Fliszar CJ, Conroy MC, et al. Contribution of the C-terminal domain of metalloproteinases to binding by the inhibitor of metalloproteinases: C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J Biol Chem 1994;269:1292-7.
5. DeClerck YA, Perez N, Shimada H, et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
6. Woessner JF Jr, Taplin C. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1988;263:16918-25.
7. Miyazaki K, Hattori Y, Umenishi F, et al. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (Pump-1), secreted from human rectal carcinoma cell line. Cancer Res 1990;50:7758-64.
8. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996;28:123-36.
9. McDonnell S, Navre M, Coffey R, et al. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinoma. Mol Carcinog 1991;4:527-33.
10. Yoshimoto M, Itoh F, Yamamoto H, et al. Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancers. Int J Cancer 1993;54:614-18.
11. Yamamoto H, Itoh F, Hinoda Y, et al. Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 1994;201:657-64.
12. Yamamoto H, Itoh F, Adachi Y, et al. Relation of enhanced secretion of active matrix metalloproteinases with tumour spread in human hepatocellular carcinoma. Gastroenterology 1997;112:1271-7.
13. Levy AT, Cioce V, Sobel ME, et al. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991;51:439-44.
14. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colon cancer. Nat Med 1996;2:461-2.
15. Pyke C, Ralfkiær E, Tryggvason K, et al. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-65.
16. Porte H, Chastre E, Prevot S, et al. Neoplastic progression of human colorectal cancer is associated with over-expression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 1995;64:70-5.
17. Okada A, Bellocq J-P, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995;92:2730-4.
18. Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 1995;72:575-82.
19. Zucker S, Lysik RM, DiMassimo BI, et al. Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer 1995;76:700-8.
20. Liabakk N-B, Talbot I, Smith RA, et al. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56:190-6.
21. Newell KJ, Witty JP, Rodgers WH, et al. Expression and localization of matrix-degrading metalloproteinases during colorectal tumourigenesis. Mol Carcinog 1994;10:199-206.
22. Mori M, Barnard GF, Mimori K, et al. Over-expression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 1995;75:1516-19.
23. Ishikawa T, Ichikawa Y, Mitsuhashi M, et al. Matrilysin is associated with progression of colorectal tumour. Cancer Lett 1996;107:5-10.
24. Yamamoto H, Itoh F, Hinoda Y, et al. Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int J Cancer 1995;61:1-5.
25. Itoh F, Yamamoto H, Hinoda Y, et al. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells. Cancer 1996;77:1717-21.
26. Sato Y, Mukai K, Watanabe S, et al. The AMeX method; a simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986;125:431-5.
27. Ohuchi E, Azumano I, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies. Clin Chim Acta 1996;244:181-98.
28. Albrecht-Buhler G. The phagokinetic tracks of 3T3 cells. Cell 1971;11:395-404.
29. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
30. Borchers AH, Powell MB, Fusenig NE, et al. Paracrine factor and cell-cell contact-mediated induction of protease and c-cts gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res 1994;213:143-7.
31. Nakajima M, Morikawa K, Fabra A, et al. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 1990;82:1890-8.
32. Powel WP, Knox JD, Navre M, et al. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 1993;53:417-22.
33. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5.
34. Imai K, Yokohama Y, Nakanishi I, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymatic properties. J Biol Chem 1995;270:6691-7.
35. Crabbe T, Smith B, O'Connell J, et al. Human progelatinase A can be activated by matrilysin. FEBS Lett 1994;345:14-16.
36. Witty JP, McDonnell S, Newell KJ, et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumourigenicity in vivo. Cancer Res 1994;54:4805-12.